SEC Asking Pfizer for Bextra, Celebrex Data

"Pfizer Inc. is responding to a request from the Securities and Exchange Commission for information and documents on its Bextra and Celebrex painkillers, the drugmaker said Tuesday in a filing." [Washington Post]